Two medical researchers from the Oxford University Hospitals NHS Trust and the University of Oxford have been elected as Fellows of the Academy of Medical Sciences.
Professors Tipu Aziz and Rury Holman are among the 46 new Fellows announced by the Academy for their outstanding contributions to the advancement of medical science, innovative application of scientific knowledge, or conspicuous service to healthcare.
Professor Tipu Aziz (left) is a professor of neurosurgery in the Nuffield Department of Surgical Sciences, based at the John Radcliffe Hospital. His work focuses on the alleviation of movement disorders and pain. His group carries out investigations into the neural signatures of pain and movement disorders, including deep brain stimulation, brain imaging and clinical neurophysiology. Professor Aziz has a long standing interest in primate models of movement disorders and was central to establishing surgical targets to alleviate Parkinson’s disease. He has also helped establish functional neurosurgery in many centres abroad and holds professorships in Porto and Aarhus.
Rury Holman (right)is a consultant physician at the Churchill Hospital and theme leader for the NIHR Oxford Biomedical Research Centre, Diabetes Theme. He is a professor of Diabetic Medicine and Director of the University of Oxford Diabetes Trials Unit. Professor Holman divides his time between clinical care of patients, teaching and his many research interests. He has designed and run many multicentre studies that focus primarily on prevention, appropriate treatment and cardiovascular risk reduction in type 2 diabetes, and is one of the most cited authors in diabetes.Professor Sir John Tooke, President of the Academy of Medical Sciences, said:
“These new Fellows represent the wealth of talent within the UK biomedical community. Excellent medical science and medical scientists are key to breakthroughs in preventing and treating ill health. I am delighted that the Academy can recognise these new Fellows for the work they have done in the generation of cutting edge science and its translation into health benefits for society.”